Replies to post #208169 on Biotech Values

[DewDiligence]

TEVA fires CEO, Erez Vigodman:

http://finance.yahoo.com/news/teva-appoints-dr-yitzhak-peterburg-215300575.html

When a sports team loses, they fire the head coach. When a company loses (on multiple fronts), they fire the CEO.

A new CEO won't solve TEVA's Copaxone problem, however.

[DewDiligence]

TARO FY3Q17 sales -15% YoY—reflecting tough pricing environment in US generics industry:

http://finance.yahoo.com/news/taro-provides-results-december-31-220500795.html

Quarter ended December 31, 2016 Highlights - compared to December 31, 2015

• Net sales of $220.4 million, decreased $37.9 million, or 14.7%, the result of continuing increased competition and the challenging pricing environment. Overall volumes increased 1%.

• Gross profit of $167.3 million decreased $46.8 million, and as a percentage of net sales, was 75.9% compared to 82.9%.

[DewDiligence]

IPXL -35% on soft 4Q16 results:

http://finance.yahoo.com/news/impax-reports-fourth-quarter-full-113500029.htmlults:

Generic-drug companies are going through tough times.